Genetic counseling for susceptibility loci and neurodevelopmental disorders: The del15q11.2 as an example

American Journal of Medical Genetics, Part A

Volumn 161, Issue 11, 2013, Pages 2846-2854

  De Wolf, Veerle ^a   Brison, Nathalie ^a   Devriendt, Koenraad ^a   Peeters, Hilde ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Del15q11.2; Genetic counseling; Neurodevelopmental disorders; Susceptibility locus

Indexed keywords

ARTICLE; ATTENTION DISTURBANCE; AUTISM; CHROMOSOME 15Q; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME DELETION 15Q11.2; COPY NUMBER VARIATION; CYFIP1 GENE; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; EPILEPSY; GENE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENOTYPE; HUMAN; INTELLECTUAL IMPAIRMENT; NEUROLOGIC DISEASE; NIPA1 GENE; NIPA2 GENE; PARENT COUNSELING; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SPEECH DELAY; TUBGCP5 GENE;

DEL15Q11.2; GENETIC COUNSELING; NEURODEVELOPMENTAL DISORDERS; SUSCEPTIBILITY LOCUS;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; DEVELOPMENTAL DISABILITIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC COUNSELING; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; ODDS RATIO; RISK FACTORS;

EID: 84886261029     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36209     Document Type: Article

References (46)

1. Abdelmoity AT, LePichon JB, Nyp SS, Soden SE, Daniel CA, Yu S. 2012. 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features. J Dev Behav Pediatr 33:570-576.
2. Baird PA, Anderson TW, Newcombe HB, Lowry RB. 1988. Genetic disorders in children and young adults: A population study. Am J Hum Genet 42:677-693.
3. Benn PA. 2013. Prenatal counseling and the detection of copy-number variants. Genet Med 15:316-317.
4. Bittel DC, Kibiryeva N, Butler MG. 2006. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Pediatrics 118:e1276-e1283.
5. Botzolakis EJ, Zhao J, Gurba KN, Macdonald RL, Hedera P. 2011. The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1. Mol Cell Neurosci 46:122-135.
6. Bozdagi O, Sakurai T, Dorr N, Pilorge M, Takahashi N, Buxbaum JD. 2012. Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice. PLoS ONE 7:e42422.
7. Burnside RD, Pasion R, Mikhail FM, Carroll AJ, Robin NH, Youngs EL, Gadi IK, Keitges E, Jaswaney VL, Papenhausen PR, Potluri VR, Risheg H, Rush B, Smith JL, Schwartz S, Tepperberg JH, Butler MG. 2011. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: A susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 130:517-5528.
8. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. 2004. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 113:565-573.
9. Carter CO. 1969. Polygenic inheritance and common diseases. Lancet 1:1252-1256.
10. Chai JH, Locke DP, Greally JM, Knoll JH, Ohta T, Dunai J, Yavor A, Eichler EE, Nicholls RD. 2003. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet 73:898-925.
11. Chen S, Song C, Guo H, Xu P, Huang W, Zhou Y, Sun J, Li CX, Du Y, Li X, Liu Z, Geng D, Maxwell PH, Zhang C, Wang Y. 2005. Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families. Hum Mutat 25:135-141.
12. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE. 2011. A copy number variation morbidity map of developmental delay. Nat Genet 43:838-846.
13. Cottrell CE, Bir N, Varga E, Alvarez CE, Bouyain S, Zernzach R, Thrush DL, Evans J, Trimarchi M, Butter EM, Cunningham D, Gastier-Foster JM, McBride KL, Herman GE. 2011. Contactin 4 as an autism susceptibility locus. Autism Res 4:189-199.
14. de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, Leu C, Kluck C, Muhle H, von Spiczak S, Ostertag P, Obermeier T, Kleefuss-Lie AA, Hallmann K, Steffens M, Gaus V, Klein KM, Hamer HM, Rosenow F, Brilstra EH, Trenite DK, Swinkels ME, Weber YG, Unterberger I, Zimprich F, Urak L, Feucht M, Fuchs K, Moller RS, Hjalgrim H, De Jonghe P, Suls A, Ruckert IM, Wichmann HE, Franke A, Schreiber S, Nurnberg P, Elger CE, Lerche H, Stephani U, Koeleman BP, Lindhout D, Eichler EE, Sander T. 2010. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 133:23-32.
15. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE. 2012. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367:1921-1929.
16. De Rubeis S, Bagni C. 2011. Regulation of molecular pathways in the fragile X syndrome: Insights into autism spectrum disorders. J Neurodev Disord 3:257-269.
17. Doornbos M, Sikkema-Raddatz B, Ruijvenkamp CA, Dijkhuizen T, Bijlsma EK, Gijsbers AC, Hilhorst-Hofstee Y, Hordijk R, Verbruggen KT, Kerstjens-Frederikse WS, van Essen T, Kok K, van Silfhout AT, Breuning M, van Ravenswaaij-Arts CM. 2009. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet 52:108-115.
18. Dykens EM, Roof E. 2008. Behavior in Prader-Willi syndrome: Relationship to genetic subtypes and age. J Child Psychol Psychiatry 49:1001-1008.
19. Flint J, Wilkie AO. 1996. The genetics of mental retardation. Br Med Bull 52:453-464.
20. Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, Itsara A, Vives L, Walsh T, McCarthy SE, Baker C, Mefford HC, Kidd JM, Browning SR, Browning BL, Dickel DE, Levy DL, Ballif BC, Platky K, Farber DM, Gowans GC, Wetherbee JJ, Asamoah A, Weaver DD, Mark PR, Dickerson J, Garg BP, Ellingwood SA, Smith R, Banks VC, Smith W, McDonald MT, Hoo JJ, French BN, Hudson C, Johnson JP, Ozmore JR, Moeschler JB, Surti U, Escobar LF, El-Khechen D, Gorski JL, Kussmann J, Salbert B, Lacassie Y, Biser A, McDonald-McGinn DM, Zackai EH, Deardorff MA, Shaikh TH, Haan E, Friend KL, Fichera M, Romano C, Gecz J, DeLisi LE, Sebat J, King MC, Shaffer LG, Eichler EE. 2010. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42:203-209.
21. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, Filipink RA, McConnell JS, Angle B, Meschino WS, Nezarati MM, Asamoah A, Jackson KE, Gowans GC, Martin JA, Carmany EP, Stockton DW, Schnur RE, Penney LS, Martin DM, Raskin S, Leppig K, Thiese H, Smith R, Aberg E, Niyazov DM, Escobar LF, El-Khechen D, Johnson KD, Lebel RR, Siefkas K, Ball S, Shur N, McGuire M, Brasington CK, Spence JE, Martin LS, Clericuzio C, Ballif BC, Shaffer LG, Eichler EE. 2012. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 367:1321-1331.
22. Goytain A, Hines RM, El-Husseini A, Quamme GA. 2007. NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem 282:8060-8068.
23. Jiang Y, Zhang Y, Zhang P, Sang T, Zhang F, Ji T, Huang Q, Xie H, Du R, Cai B, Zhao H, Wang J, Wu Y, Wu H, Xu K, Liu X, Chan P, Wu X. 2012. NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsy. Hum Genet 131:1217-1224.
24. Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P, Craddock N, Owen MJ, O'Donovan MC. 2009. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet 18:1497-1503.
25. Kommu N, Sanders S, Kaminsky E, Stankiewicz P, Martin APC, Wiszniewska J, Beaudet A. 2011. Analysis of CNVs of the BP1-BP2 region (15q11.2) suggests mild pathogenicity in autism families. American Society of Human Genetics/ICHG 2011.
26. Kumar RA. 2010. Two-hit wonder: A novel genetic model to explain variable expressivity in severe pediatric phenotypes. Clin Genet 78:517-519.
27. Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, Huguet G, Konyukh M, Chaste P, Ey E, Rastam M, Anckarsater H, Nygren G, Gillberg IC, Melke J, Toro R, Regnault B, Fauchereau F, Mercati O, Lemiere N, Skuse D, Poot M, Holt R, Monaco AP, Jarvela I, Kantojarvi K, Vanhala R, Curran S, Collier DA, Bolton P, Chiocchetti A, Klauck SM, Poustka F, Freitag CM, Waltes R, Kopp M, Duketis E, Bacchelli E, Minopoli F, Ruta L, Battaglia A, Mazzone L, Maestrini E, Sequeira AF, Oliveira B, Vicente A, Oliveira G, Pinto D, Scherer SW, Zelenika D, Delepine M, Lathrop M, Bonneau D, Guinchat V, Devillard F, Assouline B, Mouren MC, Leboyer M, Gillberg C, Boeckers TM, Bourgeron T. 2012. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8:e1002521.
28. Madrigal I, Rodriguez-Revenga L, Xuncla M, Mila M. 2012. 15q11.2 microdeletion and FMR1 premutation in a family with intellectual disabilities and autism. Gene 508:92-95.
29. Mefford HC, Cooper GM, Zerr T, Smith JD, Baker C, Shafer N, Thorland EC, Skinner C, Schwartz CE, Nickerson DA, Eichler EE. 2009. A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res 19:1579-1585.
30. Milner KM, Craig EE, Thompson RJ, Veltman MW, Thomas NS, Roberts S, Bellamy M, Curran SR, Sporikou CM, Bolton PF. 2005. Prader-Willi syndrome: Intellectual abilities and behavioural features by genetic subtype. J Child Psychol Psychiatry 46:1089-1096.
31. Murphy SM, Preble AM, Patel UK, O'Connell KL, Dias DP, Moritz M, Agard D, Stults JT, Stearns T. 2001. GCP5 and GCP6: Two new members of the human gamma-tubulin complex. Mol Biol Cell 12:3340-3352.
32. Murthy SK, Nygren AO, El Shakankiry HM, Schouten JP, Al Khayat AI, Ridha A, Al Ali MT. 2007. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet Genome Res 116:135-140.
33. Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, De Rubeis S, Di Marino D, Mohr E, Massimi M, Falconi M, Witke W, Costa-Mattioli M, Sonenberg N, Achsel T, Bagni C. 2008. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134:1042-1054.
34. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE. 2011. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43:585-589.
35. Rainier S, Chai JH, Tokarz D, Nicholls RD, Fink JK. 2003. NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet 73:967-971.
36. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM. 2012. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: An exome sequencing study. Lancet 380:1674-1682.
37. Robinson PN. 2010. Whole-exome sequencing for finding de novo mutations in sporadic mental retardation. Genome Biol 11:144.
38. Rosenfeld JA, Coe BP, Eichler EE, Cuckle H, Shaffer LG. 2012. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet Med 15:478-481.
39. Sempere Perez A, Manchon Trives I, Palazon Azorin I, Alcaraz Mas L, Perez Lledo E, Galan Sanchez F. 2011. [15Q11.2 (BP1-BP2) microdeletion, a new syndrome with variable expressivity]. An Pediatr (Barc) 75:58-562.
40. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Moller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Muhleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nothen MM, Peltonen L, Collier DA, St Clair D, Stefansson K. 2008. Large recurrent microdeletions associated with schizophrenia. Nature 455:232-236.
41. Tsang HT, Edwards TL, Wang X, Connell JW, Davies RJ, Durrington HJ, O'Kane CJ, Luzio JP, Reid E. 2009. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet 18:3805-3821.
42. Varela MC, Kok F, Setian N, Kim CA, Koiffmann CP. 2005. Impact of molecular mechanisms, including deletion size, on Prader-Willi syndrome phenotype: Study of 75 patients. Clin Genet 67:47-52.
43. Veltman JA, Brunner HG. 2010. Understanding variable expressivity in microdeletion syndromes. Nat Genet 42:192-193.
44. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BW, Hoischen A, de Vries BB, Brunner HG, Veltman JA. 2010. A de novo paradigm for mental retardation. Nat Genet 42:1109-1112.
45. von der Lippe C, Rustad C, Heimdal K, Rodningen OK. 2011. 15q11.2 microdeletion-Seven new patients with delayed development and/or behavioural problems. Eur J Med Genet 54:357-360.
46. Zhao J, Matthies DS, Botzolakis EJ, Macdonald RL, Blakely RD, Hedera P. 2008. Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism. J Neurosci 28:13938-13951.